Deferred Tax Assets, Net of Valuation Allowance in USD of BIO-TECHNE Corp from Q2 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
BIO-TECHNE Corp quarterly Deferred Tax Assets, Net of Valuation Allowance history and change rate from Q2 2010 to Q2 2025.
  • BIO-TECHNE Corp Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 30 Jun 2025 was $126M, a 15% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $126M +$16.4M +15% 30 Jun 2025 10-K 22 Aug 2025
Q2 2024 $109M +$14.3M +15% 30 Jun 2024 10-K 22 Aug 2025
Q2 2023 $95M +$18.8M +24.7% 30 Jun 2023 10-K 22 Aug 2024
Q2 2022 $76.2M -$10.7M -12.3% 30 Jun 2022 10-K 23 Aug 2023
Q2 2021 $86.9M +$13.5M +18.4% 30 Jun 2021 10-K 24 Aug 2022
Q2 2020 $73.4M +$7.76M +11.8% 30 Jun 2020 10-K 25 Aug 2021
Q2 2019 $65.6M +$25.3M +62.6% 30 Jun 2019 10-K 26 Aug 2020
Q2 2018 $40.3M -$20.1M -33.3% 30 Jun 2018 10-K/A 06 Nov 2019
Q2 2017 $60.4M +$9.92M +19.6% 30 Jun 2017 10-K 27 Aug 2018
Q2 2016 $50.5M -$7.26M -12.6% 30 Jun 2016 10-K 07 Sep 2017
Q2 2015 $57.8M +$38.9M +207% 30 Jun 2015 10-K 29 Aug 2016
Q2 2014 $18.9M -$975K -4.92% 30 Jun 2014 10-K 31 Aug 2015
Q2 2013 $19.8M +$2.93M +17.3% 30 Jun 2013 10-K 29 Aug 2014
Q2 2012 $16.9M +$8.13M +92.8% 30 Jun 2012 10-K 29 Aug 2013
Q2 2011 $8.77M -$7.93M -47.5% 30 Jun 2011 10-K 29 Aug 2012
Q2 2010 $16.7M 30 Jun 2010 10-K 29 Aug 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.